OpenAI's partnerships have pushed the value of its dealmaking to $1 trillion this year alone, and CEO Sam Altman doesn't seem to be finished.
The Chatbot Assessment Reporting Tool (CHART) guidelines, published in the BMJ and other journals in August, 2025, advise on the reporting of generative artificial intelligence (AI)-driven chatbots.